Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-115 for Partial-thickness Rotator Cuff Tear
NCT06414005Phase 3Recruiting
- Sponsor
- Tego Science
- Start
- Apr 2024
- Primary completion
- Jun 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of TPX-115 in partial-thickness rotator cuff tear (PRCT), sponsored by Tego Science. Started Apr 2024; status: recruiting.
02
Drugs
TPX-115
03
Conditions
partial-thickness rotator cuff tear (PRCT)
Beyond the preview
Go deeper on NCT06414005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06414005.